National Comprehensive Cancer Network

About NCCN

Upcoming Translations of NCCN Guidelines

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

In 2015, the National Comprehensive Cancer Network® (NCCN®) has received support from ROCHE for the translation, verification, and maintenance of the NCCN Clinical Practice Guidelines on Oncology (NCCN Guidelines®) for Breast, Cervical, Colon, Non-Small Cell, and Ovarian Cancers into the following languages: Chinese, French, Polish, Portuguese, South Korean, and Spanish.

Furthermore, additional support has been received from Millennium Pharmaceuticals, Inc. to translate the NCCN Guidelines® for Hodgkin Lymphoma, Non-Hodgkin’s Lymphomas, and Multiple Myeloma into Chinese, Korean, Portuguese, and Spanish, and from Astellas Farma Brasil to translate the NCCN Guidelines® for Prostate into Portuguese and Spanish Latin America Editions.

NCCN has consented to direct, non-adapted translations of the Complete Library of NCCN Guidelines, Version 2014 into Japanese, by a major national university in Kyoto, Japan; this agreement has been renewed for translation of Version 2015.

For more information about international adaptations and translations of NCCN Guidelines, please visit NCCN.org.